Supernus Pharmaceuticals SUPN Amortization of capitalized software and acquired intangible assets
Amortization of capitalized software and acquired intangible assets at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's amortization of capitalized software and acquired intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
- Supernus Pharmaceuticals (SUPN) reported amortization of capitalized software and acquired intangible assets of $25.64M in Q1 2026.
- How has Supernus Pharmaceuticals's amortization of capitalized software and acquired intangible assets changed year-over-year?
- Supernus Pharmaceuticals's amortization of capitalized software and acquired intangible assets increased by 29.6% year-over-year, from $19.79M to $25.64M.
- What is the long-term trend for Supernus Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
- Over 4 years (2021 to 2025), Supernus Pharmaceuticals's amortization of capitalized software and acquired intangible assets has grown at a 31.4% compound annual growth rate (CAGR), from $29.99M to $89.46M.